Tuesday, February 4, 2020

Toronto-based BenchSci, which is using AI to accelerate drug discovery research and reduce related costs, raises $22M Series B led by F-Prime Capital (Kyle Wiggers/VentureBeat)

Kyle Wiggers / VentureBeat:
Toronto-based BenchSci, which is using AI to accelerate drug discovery research and reduce related costs, raises $22M Series B led by F-Prime Capital  —  Assessing the health of pharmaceutical R&D by unearthing hidden patterns in procurement data is a task made simpler by AI.



at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

London-based Agon, which is developing sovereign AI training infrastructure for European defense, emerges from stealth with a $7M pre-seed and a $23M seed (Ingrid Lunden/Resilience Media)

Ingrid Lunden / Resilience Media : London-based Agon, which is developing sovereign AI training infrastructure for European defense, emer...